Mr. Capicchioni brings 25 years of global CRO experience to NCS. He has held a broad range of executive leadership positions, overseeing global sales, project management, marketing, client services and operations. Prior to joining NCS, Mr. Capicchioni lead a small CRO focusing on late stage clinical trials. During his tenure at Cetero Research, he lead the global business development, marketing, project management and client services teams. It was at Cetero where he was exposed to multiple mergers and helped in organizing the legal and commercial structure for the company. Mr. Capicchioni was Senior Vice President of Business Development for Global Early Clinical and Bioanalytical Research at MDS Pharma Services (now Celerion), where he directed the pharmaceutical and generic segments, and previously held senior posts at Phoenix International Life Sciences. He has served on the board of directors of the Generic Pharmaceutical Association as the elected member for Contract Research Organizations.
Mr. Capicchioni is well-known in the industry for his leadership, integrity, energy and passion. With his strong strategic focus, understanding of the marketplace and commitment to all stakeholders, he assists NCS in providing a unique form of customer advocacy, emphasizing quality, accountability, timeliness and budget management in all aspects of our customer-focused clinical research initiatives and pharmacovigilance practice. Mr. Capicchioni holds a Chemistry degree from Rutgers University.